Nuveen Asset Management, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$619,947
-48.4%
55,501
-1.1%
0.00%
Q2 2023$1,200,454
+52806.7%
56,0960.0%0.00%
-100.0%
Q1 2023$2,269
-20.6%
56,096
-8.6%
0.00%0.0%
Q4 2022$2,856
-99.9%
61,380
-12.9%
0.00%0.0%
Q3 2022$3,656,000
+7.4%
70,475
-2.1%
0.00%0.0%
Q2 2022$3,404,000
-64.8%
72,018
-50.5%
0.00%
-66.7%
Q1 2022$9,669,000
+51.2%
145,480
+51.3%
0.00%
+50.0%
Q4 2021$6,395,000
+34.2%
96,158
+17.9%
0.00%
+100.0%
Q3 2021$4,764,000
+33.4%
81,546
+0.5%
0.00%0.0%
Q2 2021$3,572,000
-14.8%
81,156
-4.5%
0.00%0.0%
Q1 2021$4,193,000
+13.8%
85,019
-2.8%
0.00%0.0%
Q4 2020$3,683,000
-11.2%
87,473
-3.4%
0.00%
-50.0%
Q3 2020$4,147,000
-26.3%
90,587
-19.2%
0.00%0.0%
Q2 2020$5,629,000
+10.7%
112,114
+13.4%
0.00%0.0%
Q1 2020$5,083,000
-30.1%
98,832
-16.0%
0.00%
-33.3%
Q4 2019$7,268,000
-42.3%
117,651
-43.9%
0.00%
-40.0%
Q3 2019$12,603,000
-24.5%
209,769
+6.1%
0.01%
-28.6%
Q2 2019$16,686,000197,7510.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 511,186$43,686,00011.23%
GREAT POINT PARTNERS LLC 210,400$17,981,0002.80%
ARMISTICE CAPITAL, LLC 456,000$38,970,0002.34%
Matarin Capital Management, LLC 210,208$17,964,376,0001.16%
Sapphire Star Partners LP 8,168$698,0000.70%
Granahan Investment Management 103,320$8,830,0000.48%
FARALLON CAPITAL MANAGEMENT LLC 867,500$74,137,0000.44%
361 CAPITAL LLC 19,040$1,627,0000.35%
ALGERT GLOBAL LLC 17,922$1,532,0000.33%
AlphaMark Advisors, LLC 9,310$796,0000.32%
View complete list of ENANTA PHARMACEUTICALS INC shareholders